Menu

Exercise Warms the Brain, Causing Mice to Eat Less

Directly activating a heat sensor also sensitive to capsaicin in chili peppers in the hypothalamus had the same effect as exercise.

Apr 24, 2018
Kerry Grens

ISTOCK, ANYAIVANOVAThermometers in the mouse brain are responsible for a lack of appetite the animals feel after a vigorous workout. Simply firing up heat-sensing receptors on cells in the mouse hypothalamus can reproduce the same appetite-suppressing effects of exercise, researchers report today (April 24) in PLOS Biology.

“Our study provides evidence that body temperature can act as a biological signal that regulates feeding behavior, just like hormones and nutrients do,” says coauthor Young-Hwan Jo, a neuroscientist at Albert Einstein College of Medicine, in a press release.

It’s a fairly common observation among people that working out staves off hunger for a short while afterward. And it turns out the same is true in mice. Jo’s group had mice run a treadmill for 40 minutes, and observed that their brains were warmer and they ate less for the next hour. To see what might be responsible for this effect, Jo and his colleagues centered in on the hypothalamus, given its role in regulating eating.

They found that in mice, neurons in the hypothalamus—specifically, in the arcuate nucleus (ARC) of the hypothalamus—produce heat-sensitive receptors called TRPV1. Through a variety of methods, including the application of capsaicin, a compound found in hot chili peppers, the investigators revealed that flipping on TRPV1 could tamp down mice’s appetites. On the flip side, disrupting the receptor wiped out the appetite-suppressing effects of exercise.

“Hence, our results propose that elevated hypothalamic temperature can activate temperature-sensitive TRPV1-like receptors in [these] neurons, which may result in a reduction in food intake,” the researchers write in their report.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.